93 related articles for article (PubMed ID: 1997107)
1. Poor prognosis for malignant melanoma in Northern Ireland: a multivariate analysis.
Gordon LG; Lowry WS; Pedlow PJ; Patterson CC
Br J Cancer; 1991 Feb; 63(2):283-6. PubMed ID: 1997107
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.
Ingkaninanda P; Visessiri Y; Rutnin S
J Med Assoc Thai; 2015 Aug; 98(8):820-7. PubMed ID: 26437541
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in malignant melanoma of the choroid: a retrospective survey of cases occurring in Northern Ireland between 1965 and 1980.
Kidd MN; Lyness RW; Patterson CC; Johnston PB; Archer DB
Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 1)():114-21. PubMed ID: 3459295
[TBL] [Abstract][Full Text] [Related]
5. The incidence and pathogenesis of invasive cutaneous malignant melanoma in Northern Ireland.
Gordon LG; Lowry WS
Br J Cancer; 1986 Jan; 53(1):75-80. PubMed ID: 3947518
[TBL] [Abstract][Full Text] [Related]
6. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features and prognostic factors in patients with non-cutaneous malignant melanoma: a single-center retrospective study of 71 cases.
Zhu H; Dong D; Li F; Liu D; Wang L; Fu J; Song L; Xu G
Int J Dermatol; 2015 Dec; 54(12):1390-5. PubMed ID: 26016703
[TBL] [Abstract][Full Text] [Related]
8. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
[TBL] [Abstract][Full Text] [Related]
9. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
Barnhill RL; Fine JA; Roush GC; Berwick M
Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
[TBL] [Abstract][Full Text] [Related]
10. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
[TBL] [Abstract][Full Text] [Related]
11. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
12. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
Uehara S; Kamo R; Harada T; Ishii M
Osaka City Med J; 2009 Jun; 55(1):35-52. PubMed ID: 19725433
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland.
Montella A; Gavin A; Middleton R; Autier P; Boniol M
Eur J Cancer; 2009 Sep; 45(13):2360-6. PubMed ID: 19375307
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological features of cutaneous malignant melanoma: a retrospective analysis of 124 Japanese patients.
Kuno Y; Ishihara K; Yamazaki N; Mukai K
Jpn J Clin Oncol; 1996 Jun; 26(3):144-51. PubMed ID: 8656554
[TBL] [Abstract][Full Text] [Related]
16. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.
Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C
Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697
[TBL] [Abstract][Full Text] [Related]
17. Acral Lentiginous Melanoma - misdiagnosis, referral delay and 5 years specific survival according to site.
Boriani F; O'Leary F; Tohill M; Orlando A
Eur Rev Med Pharmacol Sci; 2014; 18(14):1990-6. PubMed ID: 25027337
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.
Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J
Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tumour thickness in cutaneous malignant melanoma.
Jeffrey I; Royston P; Sowter C; Slavin G; Price A; Pomerance A; Goolamali S; Pinto D
J Clin Pathol; 1983 Jan; 36(1):51-6. PubMed ID: 6822677
[TBL] [Abstract][Full Text] [Related]
20. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
